A complete application in a minute — tailored resume and cover letter, ready to send.
As a Marketing Associate at Sequential, you will play a critical role in shaping our brand, product(s) and ensuring our scientific expertise is communicated to the personal care and dermo-cosmetics industries. You will support the execution of marketing strategies that drive awareness, engagement and lead generation efforts to amplify Sequential’s footprint and contribute to commercial growth. Working closely with the Head of Marketing and cross‑functional teams, you’ll help bring Sequential’s unique value proposition to life across digital channels, campaigns and tradeshows (+ conferences). This is an exciting opportunity for a creative, detail‑oriented marketer to gain hands‑on experience in a fast‑growing biotech company at the forefront of microbiome and human biomarker testing innovation.
An ideal candidate should have the drive to quickly learn our scientific offering to be able to translate them into strong marketable assets. We are looking for someone who will hit the ground running and be able to integrate into the team seamlessly. 3-6 months into the role, we expect a concrete understanding of our offerings, the ability to support in marketing efforts, and have ownership of individual duties and tasks to ensure smooth execution of overarching marketing strategies. Our end clients are B2B companies who operate in both personal care and pharma industries. Both these target groups require different marketing tactics to reach. In order to succeed within this role, a deep understanding of these industries, their pain points and objections will be critical.
Sequential is an established global leader in clinical product testing for the personal care and dermo‑cosmetics industries. Formed by a team of PhD experts in genetics, epigenetics, and microbiome research, the company specializes in microbiome and human biomarker testing to champion topical products’ impacts in real‑use cases across skin, scalp, oral, and vulvovaginal formulations. The company is an Innovate UK and Enterprise Singapore‑backed company, with labs in Cambridge, New York City and Singapore.
Awarded the title "Most Significant" Testing Solution in the Industry - (C&T, 2022).
To date, Sequential has amassed over 50,000 human skin microbiome samples and corresponding formulations tested clinically. With this vast genomic dataset, Sequential is figuring out optimal formulations that could potentially alleviate skin conditions, such as for acne, atopic dermatitis and rosacea. The company has been supported by Innovate UK, Enterprise SG, A*STAR (Genome Institute of Singapore). They have raised $5MM USD to date from SOSV, Metaplanet, Scrum Ventures, Corundum Systems Biology.